CN102579748A - 一种治疗妇女乳腺增生的中药制剂 - Google Patents
一种治疗妇女乳腺增生的中药制剂 Download PDFInfo
- Publication number
- CN102579748A CN102579748A CN201210022655XA CN201210022655A CN102579748A CN 102579748 A CN102579748 A CN 102579748A CN 201210022655X A CN201210022655X A CN 201210022655XA CN 201210022655 A CN201210022655 A CN 201210022655A CN 102579748 A CN102579748 A CN 102579748A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- chinese medicine
- mammary glands
- treating hyperplasia
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 210000005075 mammary gland Anatomy 0.000 title claims abstract description 19
- 206010020718 hyperplasia Diseases 0.000 title claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000218176 Corydalis Species 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000000741 silica gel Substances 0.000 claims abstract description 6
- 229910002027 silica gel Inorganic materials 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 32
- 241000628997 Flos Species 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 4
- -1 correctives Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 201000010099 disease Diseases 0.000 abstract description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 15
- 210000004185 liver Anatomy 0.000 abstract description 15
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000179560 Prunella vulgaris Species 0.000 abstract 2
- 241000220317 Rosa Species 0.000 abstract 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 2
- 235000008113 selfheal Nutrition 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 230000005906 menstruation Effects 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 5
- 230000023555 blood coagulation Effects 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 230000003419 expectorant effect Effects 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210022655.XA CN102579748B (zh) | 2012-02-01 | 2012-02-01 | 一种治疗妇女乳腺增生的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210022655.XA CN102579748B (zh) | 2012-02-01 | 2012-02-01 | 一种治疗妇女乳腺增生的中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102579748A true CN102579748A (zh) | 2012-07-18 |
CN102579748B CN102579748B (zh) | 2017-06-30 |
Family
ID=46469350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210022655.XA Active CN102579748B (zh) | 2012-02-01 | 2012-02-01 | 一种治疗妇女乳腺增生的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102579748B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687398A (zh) * | 2016-03-11 | 2016-06-22 | 李美霞 | 一种治疗气郁痰结型乳腺增生的中药 |
CN107693658A (zh) * | 2017-11-09 | 2018-02-16 | 刘燚 | 一种治疗乳腺增生的中药散剂及使用方法 |
CN109248257A (zh) * | 2018-11-19 | 2019-01-22 | 亳州市君臣佐使药业有限公司 | 一种消肿散结的中药制剂及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010076810A (ko) * | 2000-01-28 | 2001-08-16 | 문성수 | 전립선 질환 및 치질 치료용 조성물의 제조방법 및 그제조방법에 의한 조성물 |
CN101095825A (zh) * | 2007-07-10 | 2008-01-02 | 西安千禾药业有限责任公司 | 一种治疗乳腺增生、乳腺炎的中成药及其制备方法 |
CN101168018A (zh) * | 2006-10-27 | 2008-04-30 | 杨文龙 | 乳癖康胶囊的制备方法 |
CN102406245A (zh) * | 2011-11-07 | 2012-04-11 | 胡红节 | 一种含红豆杉的文胸 |
-
2012
- 2012-02-01 CN CN201210022655.XA patent/CN102579748B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010076810A (ko) * | 2000-01-28 | 2001-08-16 | 문성수 | 전립선 질환 및 치질 치료용 조성물의 제조방법 및 그제조방법에 의한 조성물 |
CN101168018A (zh) * | 2006-10-27 | 2008-04-30 | 杨文龙 | 乳癖康胶囊的制备方法 |
CN101095825A (zh) * | 2007-07-10 | 2008-01-02 | 西安千禾药业有限责任公司 | 一种治疗乳腺增生、乳腺炎的中成药及其制备方法 |
CN102406245A (zh) * | 2011-11-07 | 2012-04-11 | 胡红节 | 一种含红豆杉的文胸 |
Non-Patent Citations (1)
Title |
---|
刘建平等: "《当代妇科名方验方大全》", 30 April 2011, 广东科技出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687398A (zh) * | 2016-03-11 | 2016-06-22 | 李美霞 | 一种治疗气郁痰结型乳腺增生的中药 |
CN107693658A (zh) * | 2017-11-09 | 2018-02-16 | 刘燚 | 一种治疗乳腺增生的中药散剂及使用方法 |
CN109248257A (zh) * | 2018-11-19 | 2019-01-22 | 亳州市君臣佐使药业有限公司 | 一种消肿散结的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102579748B (zh) | 2017-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (zh) | 一种治疗痛经的外用贴膏 | |
CN102670961B (zh) | 一种治疗中老年习惯性便秘的中药 | |
CN104523865A (zh) | 一种治疗乳腺疾病的药物 | |
CN102370948A (zh) | 一种治疗乳腺增生的中药复方制剂及其制备方法 | |
CN102120020B (zh) | 一种治疗乳腺增生病和子宫肌瘤的药物组合物及其制备方法 | |
CN103386022A (zh) | 一种治疗结核性胸膜炎的中药组合物 | |
Lin et al. | Herb pairs containing Curcumae Rhizoma (Ezhu): A review of bio-active constituents, compatibility effects and t-copula function analysis | |
CN101518640A (zh) | 治疗肿瘤中药方 | |
CN102579748A (zh) | 一种治疗妇女乳腺增生的中药制剂 | |
CN102688374A (zh) | 一种用于治疗乳腺增生的药物 | |
CN1709326A (zh) | 一种治疗乳腺增生疾病的浓缩丸制备方法 | |
CN103127272A (zh) | 一种治疗乳腺疾病的中药制剂及其制备方法 | |
CN102940765A (zh) | 一种治疗乳腺癌的药物及其制备方法 | |
CN102526509B (zh) | 一种治疗肝肿大的药物 | |
CN101983666A (zh) | 一种治疗风湿病的中药组合物及其制备方法 | |
CN102100816A (zh) | 治疗风寒感冒的中药制剂 | |
CN105687543A (zh) | 一种治疗肿瘤的外用中药制剂 | |
CN104435641A (zh) | 治疗甲状腺功能亢进症的中药制剂 | |
CN104027430A (zh) | 一种治疗血瘀型子宫肌瘤的中药组合物 | |
CN104288579A (zh) | 一种用于治疗慢性肾炎的中药及其制备方法 | |
CN103494939A (zh) | 一种治疗老年习惯性便秘的中药 | |
CN103585545A (zh) | 一种治疗中耳炎的中药组合物 | |
CN104147229B (zh) | 一种治疗女性更年期综合征肾阴阳两虚型的中药复方制剂 | |
CN102379913B (zh) | 治疗子宫复旧不全的药物组合物及其制备方法和用途 | |
CN103127439B (zh) | 一种治疗结肠炎和肠炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: YAOGU SCI-TECH DEVELOPMENT CO., LTD., WUHAN Effective date: 20121015 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430079 WUHAN, HUBEI PROVINCE TO: 300410 BEICHEN, TIANJIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121015 Address after: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 (city of the modern Chinese Medicine) Applicant after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 430079 Hubei city of Wuhan province East Lake high tech Development Zone Road No. 858 Pharmaceutical Industrial Park building A2-2 Wuhan yaogoo Technology Development Co. Ltd. Applicant before: WUHAN YAOGU TECHNOLOGY DEVELOPMENT CO.,LTD. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Address before: 300410 Tianjin City Hedong District of Beichen Puji Road No. 2 (city of the modern Chinese Medicine) Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240521 Address after: 300410 2 East Road Puji River, Beichen District, Tianjin (Tsun Li modern Chinese medicine city) Patentee after: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Country or region after: China Patentee after: Tianjin Tasly Modern TCM Resources Co.,Ltd. Address before: 300410 Tianjin Beichen District Huaihe road and Ting Jiang West Road intersection heaven proud of the park Legal Center Intellectual Property Department Patentee before: TASLY PHARMACEUTICAL GROUP Co.,Ltd. Country or region before: China |